Literature DB >> 1836064

Potentiation of pentazocine conditioned place preference by tripelennamine in rats.

T Suzuki1, Y Masukawa, Y Shiozaki, M Misawa.   

Abstract

The effects of tripelennamine on place preference conditioning in rats with pentazocine were investigated. Pentazocine at a dose of 2 mg/kg (IP) slightly, but not significantly, induced a place preference. Concurrent dosing of pentazocine (2 mg/kg, IP) and tripelennamine (2.5 mg/kg, SC) significantly and prominently produced a place preference, although administration of tripelennamine (2.5 mg/kg, SC) alone did not. Chronic infusion of a dopamine D1 receptor antagonist, SCH23390 (1.0 mg/kg/day) during conditioning abolished the appetitive effect of pentazocine potentiated by the combination with tripelennamine. In conclusion, it is suggested that the dopaminergic system, especially at the D1 receptor, plays an important role in the potentiation effect of tripelennamine on the pentazocine-induced place preference.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836064     DOI: 10.1007/bf02316857

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital.

Authors:  S M Evans; C E Johanson
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

2.  Some behavioral effects of histamine H1 antagonists in squirrel monkeys.

Authors:  J Bergman; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

3.  Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists.

Authors:  T S Shippenberg; A Herz
Journal:  Brain Res       Date:  1987-12-08       Impact factor: 3.252

4.  Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

Authors:  R F Mucha; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Drug interactions in the reinforcing effects of over-the-counter cough syrups.

Authors:  T Suzuki; Y Masukawa; M Misawa
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.

Authors:  E Tagashira; J F Kachur; W H Carter; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  1984-10       Impact factor: 4.030

7.  The pharmacokinetics of pentazocine and tripelennamine.

Authors:  S Y Yeh; G D Todd; R E Johnson; C W Gorodetzky; W R Lange
Journal:  Clin Pharmacol Ther       Date:  1986-06       Impact factor: 6.875

8.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Pentazocine and tripelennamine: a drug abuse epidemic?

Authors:  H W Lahmeyer; R G Steingold
Journal:  Int J Addict       Date:  1980-11

10.  Potentiation of pentazocine antinociception by tripelennamine in the rat.

Authors:  S Y Yeh
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  6 in total

1.  The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward.

Authors:  Christian Brabant; Etienne Quertemont; Christelle Anaclet; Jian-Sheng Lin; Hiroshi Ohtsu; Ezio Tirelli
Journal:  Psychopharmacology (Berl)       Date:  2006-10-28       Impact factor: 4.530

2.  Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain.

Authors:  R Oishi; S Shishido; M Yamori; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

3.  Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines.

Authors:  Y Masukawa; T Suzuki; M Misawa
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice.

Authors:  Junzo Kamei; Kayo Morita; Shigeo Miyata; Kenji Onodera
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

5.  Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.

Authors:  Lawrence Toll; Taline V Khroyan; Willma E Polgar; Faming Jiang; Cris Olsen; Nurulain T Zaveri
Journal:  J Pharmacol Exp Ther       Date:  2009-09-22       Impact factor: 4.030

6.  Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Pharmacol Biochem Behav       Date:  2008-10-07       Impact factor: 3.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.